article thumbnail

Investing Principles: Lessons Learned from 20 Years of Wins, Losses, and Strikeouts

Mergers and Inquisitions

Investing Principles: Why a High Income Trumps Everything Else Between 2009 and 2014, I did not have a traditional portfolio via a brokerage firm. The post Investing Principles: Lessons Learned from 20 Years of Wins, Losses, and Strikeouts appeared first on Mergers & Inquisitions. Youll get bored in about a week.

article thumbnail

Cybersecurity M&A Update, Q2 2025

Solganick & Co.

Established in 2009 with offices in Dallas and Los Angeles. You can download the complete report here: Solganick Cybersecurity M&A Update – Q2 2025 About Solganick Solganick is a data-driven investment bank and M&A advisory firm exclusively focused on software and technology services companies.

M&A 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Technology Services Mergers and Acquisitions (M&A) Update, 1H 2025 (Q1 and Q2 2025)

Solganick & Co.

Since 2009, the firm has gained recognition as a top investment bank and has completed over 200 transactions to date. For more information or to inquire about an M&A transaction, please contact us.

article thumbnail

Reap What You Sow – UK’s Unallowable Purpose Rule Considered Again

JD Supra: Mergers

In Syngenta Holding Limited v HMRC [2024] UKFTT 998 (TC) (Syngenta), the UKs First-tier Tribunal (FTT) denied a deduction for interest on an intra-group loan on the basis that the loan had an unallowable purpose for the purposes of section 411 of the Corporation Tax Act 2009 (CTA 2009). By: Cadwalader, Wickersham & Taft LLP

article thumbnail

Healthcare & Life Sciences Private Equity Deal Tracker: Accel-KKR Acquires VisiQuate

JD Supra: Mergers

VisiQuate, founded in 2009 and based in Santa Rosa, California, is a provider of revenue cycle management and analytics solutions for health systems. Accel-KKR has acquired VisiQuate, according to a news release. By: McGuireWoods LLP

article thumbnail

The European Commission report on competition enforcement in the pharmaceutical sector

JD Supra: Mergers

The report looks at enforcement from 2018 - 2022 and is a follow-up of the previous report which covered 2009 - 2017. By: Hogan Lovells

article thumbnail

A Capital Blow for Deducting Management Expenses

JD Supra: Mergers

The decision also confirms that once a company has decided in principle to dispose of a capital asset, any professional fees incurred afterwards in pursuance of that sale are likely to be capital and not deductible under CTA 2009 s 1219, even if a purchaser for that asset has not yet been identified and a specific sale transaction has not yet.

Capital 165